Market View

The U.S. market remains in a Confirmed Uptrend. This week, the S&P 500 fell 0.4% while the Nasdaq fell 1.4%. Both indices bounced from 21-DMA support (4,936/15,582) but closed a bit off the highs established on Monday. The S&P 500 is still well into all-time highs while the Nasdaq is about 2% below its Q4 2021 peak (16,212). Indices are about 4% extended from their 50-DMA (4,813/15,134). The distribution day count stands at five and four, respectively, after each index picked two this week (Tuesday and Friday).

O’Neil Health Care Weekly

XLV gained 1.4% last week, pacing the S&P 500 and breaking into new all-time highs. The 21-DMA ($141.15) has been acting as a solid level of near-term support since November. Despite a steady trend higher, the RS line remains in a longer-term downtrend as Health Care leadership remains narrow and unable to keep up with the Tech heavy rally. We continue to recommend an equal-to underweight sector positioning, which will likely change should the broader tape come under pressure.

O’Neil Health Care Weekly

XLV rose 195bps last week, making a new 52-week high. Near-term support remains the rising 21-DMA ($139.51) with the next level of resistance at the all-time high of $143.42. Though technical action remains positive, the overall rally within the sector has been narrow. Further, its RS line remains in a longer-term downtrend, unable to make higher highs and still warranting an under-to-equal weight sector positioning.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq were up 1.4% and 1.1%, respectively, this week. The indices rose for a fourth week and for the thirteenth time in 14 weeks. Indices bounced from support at respective 21-DMAs (4,840/15,228) and once again made new 52-week (S&P 500 made all-time) highs to end the week. The distribution day count for both indices remains at six and three, respectively. However, four distribution days on the S&P 500 and two on the Nasdaq are set to expire next week.

O’Neil Health Care Weekly

XLV traded relatively flat last week, falling 14bps and testing support at its 21-DMA ($138.50). The sector is still consolidating with resistance between $141.56 and $143.42 (all-time highs). Its RS line pulled back sharply, warranting an under-to- equal-weight sector positioning.

Market View

The U.S. market is in a Confirmed Uptrend. Indices gained ~1% for the week as the S&P 500 continues to trade near all-time
highs while the Nasdaq is only ~5% off its all-time high of ~16,200. Support for both indices is at their respective rising 10-DMA
(4,840/15,282). The distribution day count stands at five and two, respectively, with none expiring next week.

O’Neil Health Care Weekly

XLV declined 75bps last week, pulling back to 21-DMA ($137.97) support after becoming short-term overbought. The sector is still testing resistance between $141.77 and $143.42 (all-time highs). Its RS line pulled back sharply last week, warranting an equal-weight sector positioning.

Market View

The U.S. market has been shifted back to a Confirmed Uptrend from Uptrend Under Pressure. The S&P 500 gained 1.2%
for the week, breaking into fresh all-time highs after rising from support at its 21-DMA. The Nasdaq rose 2.3% and pushed above its
December peak of 15,150 to make new two-year highs. First support for the indices is once again the rising 10-DMA (4,769/14,928).
The S&P 500 has no remaining overhead, while the Nasdaq is about 4% below the next level of potential resistance from December
2021 peak of ~15,900. The distribution day count stands at six and three, respectively, with none set to expire next week.

IPO Rewind

Attached is our monthly IPO Rewind report. This report identifies a select group of IPOs or spin-offs that have priced in the last two years, giving them time to digest any initial volatility. Our selected ideas display positive fundamental trends with strong top- and bottom-line consensus estimates, and IPO Rewind provides an efficient way to review these ideas that we believe warrant attention.